Warehouse Stock Clearance Sale

Grab a bargain today!

David, P


Product Description
Product Details

About the Author

Peter David is one of the industry's most prolific and versatile writers whose record-breaking stint on Incredible Hulk remains a fan-favorite to this day. His similarly long-running - and critically acclaimed - association with X-Factor began in the early 1990s and continued in 2005. His other Marvel work includes Captain Marvel, two lengthy stints on Spider-Man 2099, Ben Reilly- Scarlet Spider and the smash-hit Symbiote Spider-Man limited series with artist Greg Land. David is also a novelist and screenwriter. Among his credits are some forty Star Trek tie-ins; original novels such as Sir Apropos of Nothing, Howling Mad and Knight Life; movies Trancers 4 and Trancers 5; and episodes of Babylon 5 and Crusade. He also co-created the TV show Space Cases with actor-writer Bill Mumy.

Dan Slott has built a loyal fan base by combining old-school fun with stories and characterizations friendly to new readers. Following his run on She-Hulk, Slott moved into the upper echelon of Marvel writers, launching Avengers- The Initiative and taking the reins on Mighty Avengers from Brian Michael Bendis. When Marvel gave Spider-Man a fresh start in 2008, Slott was one of several rotating writers on the thrice-monthly Amazing Spider-Man. Slott became the writer most closely identified with the web-slinger's "Brand New Day" era, and the title hit the "Big Time" when he took over as full-time writer for a decade-long run. Slott has also turned his talents to other iconic Marvel heroes - including soaring the spaceways with Silver Surfer; helming Tony Stark- Iron Man toward Iron Man 2020; and masterminding the glorious return of Fantastic Four, leading to his long-awaited "Reckoning War." In 2022, Slott made his way back to the Spider-Verse, teaming with legendary penciler Mark Bagley on Spider-Man.

After co-creating DC's Swamp Thing in 1972, Len Wein moved to Marvel for lengthy runs on some of the company's biggest titles - Amazing Spider-Man, Fantastic Four, Incredible Hulk and Thor - and helped bring the landmark Giant-Size X-Men #1 into the world, changing Marvel forever. Returning to DC as an editor, Wein oversaw an influx of British writing talent, highlighted by Alan Moore's historic Watchmen miniseries. Wein also has worked in television and animation, returning to his roots to develop a Swamp Thing screenplay. He has written comic-book adaptations of The Simpsons and Futurama.

A native of Ireland, artist Will Sliney got his start working for small presses in the UK and Ireland. He has since illustrated Boom! Studios' Farscape- Strange Retractors, DC Comics' Zuda webcomic The Symptoms and Marvel's Fearless Defenders. Sliney is a member of the Eclectic Micks, a sketchblog of Irish professional comics artists.

Three different incarnations of Cloak and Dagger were only a few of Rick Leonardi's artistic achievements for Marvel. His other credits include Uncanny X-Men, New Mutants and Spider-Man 2099. At DC, he drew Batman family titles Batgirl and Nightwing, as well as comic/film crossover Green Lantern vs. Aliens. At Event Comics, he penciled Painkiller Jane.

The pencils of Ryan Stegman first gained rave reviews in the Marvel adaptation of Raymond E. Feist's Magician Apprentice and Riftwar. The popularity of his work there led to assignments on Incredible Hulk, Marvel Adventures Spider-Man, Incredible Hercules and She-Hulks. With writer Christopher Yost, he launched a new incarnation of Scarlet Spider; with Dan Slott, he shocked fans with Superior Spider-Man; and with Gerry Conway, he offered a different take on the wall-crawler and his family in Amazing Spider-Man- Renew Your Vows. Stegman's other Marvel credits include Wolverine, Inhuman and Uncanny Avengers as well as his smash-hit run on Venom.

Ask a Question About this Product More...
Item ships from and is sold by Fishpond.com, Inc.

Back to top
We use essential and some optional cookies to provide you the best shopping experience. Visit our cookies policy page for more information.